(Q54732953)

3 June 2018

editorial

0 references

title

Does diabetes therapy influence the risk of cancer? (English)

1 reference

3 June 2018

2

E A M Gale

1 reference

3 June 2018

author name string

U Smith

series ordinal

1

1 reference

3 June 2018

publication date

1 September 2009

1 reference

3 June 2018

published in

Diabetologia

1 reference

3 June 2018

volume

52

1 reference

3 June 2018

issue

9

1 reference

3 June 2018

page(s)

1699-1708

1 reference

3 June 2018

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1441-5

Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1441-5

Why we need observational studies to evaluate the effectiveness of health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1441-5

Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1441-5

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1441-5

Mortality in people with Type 2 diabetes in the UK

21 January 2018

1 reference

12 December 2020

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

1 reference

12 December 2020

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

1 reference

12 December 2020

The IGF‐1 receptor in cancer biology

1 reference

12 December 2020

1 reference

12 December 2020

Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor

1 reference

12 December 2020

Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay

1 reference

12 December 2020

Inhaled insulin: gone with the wind?

1 reference

12 December 2020

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

1 reference

12 December 2020

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas

1 reference

12 December 2020

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

1 reference

12 December 2020

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

12 December 2020

Metabolic syndrome, hyperinsulinemia, and cancer

1 reference

12 December 2020

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

1 reference

12 December 2020

A genetic link between type 2 diabetes and prostate cancer

1 reference

12 December 2020

Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine

1 reference

12 December 2020

Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

Insulin like growth factor-1 and insulin-like growth factor binding proteins: their possible roles in both maintaining normal retinal vascular function and in promoting retinal pathology

1 reference

12 December 2020

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

12 December 2020

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

1 reference

12 December 2020

AMP-activated protein kinase: Role in metabolism and therapeutic implications

1 reference

12 December 2020

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

12 December 2020

Enhancing CD8 T-cell memory by modulating fatty acid metabolism

1 reference

12 December 2020

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

1 reference

12 December 2020

Diabetes mellitus and risk of breast cancer: a meta-analysis

1 reference

12 December 2020

The role of the IGF system in cancer growth and metastasis: overview and recent insights

1 reference

12 December 2020

Prevention of pancreatic cancer induction in hamsters by metformin

1 reference

12 December 2020

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

1 reference

12 December 2020

Nice insulins, pity about the evidence

1 reference

12 December 2020

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients

1 reference

12 December 2020

Insulin analogues and carcinoma of the breast

1 reference

12 December 2020

Biotransformation of insulin glargine after subcutaneous injection in healthy subjects

1 reference

12 December 2020

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

1 reference

12 December 2020

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

12 December 2020

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

12 December 2020

Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin

1 reference

12 December 2020

Novel insulin analogues and its mitogenic potential

1 reference

12 December 2020

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.

1 reference

12 December 2020

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

12 December 2020

Metformin and reduced risk of cancer in diabetic patients

1 reference

12 December 2020

Cancer as an endocrine problem

1 reference

12 December 2020

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

12 December 2020

Safety of insulin glargine

1 reference

12 December 2020

Signalling through IGF-I and insulin receptors: where is the specificity?

1 reference

12 December 2020

Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice.

1 reference

12 December 2020

10.1007/S00125-009-1441-5

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018